1. Camptothecin inhibits the progression of NPC by regulating TGF‑β‑induced activation of the PI3K/AKT signaling pathway
   Ben‑Shan Li et al, 2018, Oncology Letters CrossRef
2. Evodiamine and rutaecarpine alkaloids as highly selective transient receptor potential vanilloid 1 agonists
   Bojidarka Ivanova et al, 2014, International Journal of Biological Macromolecules CrossRef
3. Network pharmacology combined with functional metabolomics discover bile acid metabolism as a promising target for mirabilite against colorectal cancer
   Hui Sun et al, 2018, RSC Advances CrossRef
4. Camptothecin and analogs: role in anticancer activities
   P.B. Raghavendra, 2020, Camptothecin and Camptothecin Producing Plants CrossRef
5. Topoisomerase 1B poisons: Over a half‐century of drug leads, clinical candidates, and serendipitous discoveries
   Maris A. Cinelli, 2019, Medicinal Research Reviews CrossRef
6. Anti-Obesity Drug Orlistat Alleviates Western-Diet-Driven Colitis-Associated Colon Cancer via Inhibition of STAT3 and NF-κB-Mediated Signaling
   Bo-Ram Jin et al, 2021, Cells CrossRef
7. Camptothecin Inhibits Neddylation to Activate the Protective Autophagy Through NF-κB/AMPK/mTOR/ULK1 Axis in Human Esophageal Cancer Cells
   Yongqing Heng et al, 2021, Frontiers in Oncology CrossRef
8. The benzylisoquinoline alkaloids, berberine and coptisine, act against camptothecin-resistant topoisomerase I mutants
   Naomi Inoue et al, 2021, Scientific Reports CrossRef
9. Synergy between human DNA ligase I and topoisomerase 1 unveils new therapeutic strategy for the management of colorectal cancer
   Pooja Maurya et al, 2024, Journal of Biomolecular Structure and Dynamics CrossRef
10. Topoisomerases: Resistance versus Sensitivity, How Far We Can Go?
    Sandhya Bansal et al, 2017, Medicinal Research Reviews CrossRef
11. Substitutions in Spodoptera exigua topoisomerase I modulate its relaxation activity and camptothecin sensitivity
    Pei Zhang et al, 2017, Pest Management Science CrossRef